Tb-434

N/A

Report date: 2026/03/19 16:57:27

Base Information

Drug NameTb-434
Drug Alias NameAnti-CD3/undisclosed target T-cell engager (Biotecnol/Chiome Bioscience)Multispecific T cell engager antibodies (Biotecnol/Chiome Bioscience)Multispecific T cell engager antibodies (Biotecnol/Chiome Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotecnol Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiotecnol LtdChiome Bioscience Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A